Sign Up Today and Learn More About Vivace Therapeutics Stock
Invest in or calculate the value of your shares in Vivace Therapeutics or other pre-IPO companies through EquityZen's platform.
Vivace Therapeutics Stock (VITH)
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
About Vivace Therapeutics Stock
Founded
2014
Headquarters
San Mateo, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
Vivace Therapeutics Press Mentions
Stay in the know about the latest news on Vivace Therapeutics
Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight
globenewswire • Apr 21, 2025
Bicyclic compounds
patents • Apr 02, 2025
Vivace Therapeutics: $35 Million (Series D) Raised For Supporting Development Of Cancer Drug Targeting Hippo Pathway
pulse2 • Mar 17, 2025
Vivace Therapeutics Secures $35 Million in Series D Financing for Cancer Therapies Development
venturecapital • Mar 13, 2025
Vivace Therapeutics Nets $35 Million in Series D Financing
vcnewsdaily • Mar 13, 2025
Vivace Therapeutics Management
Leadership team at Vivace Therapeutics
President and Chief Executive Officer
Sofie Qiao
Board Member
Dr. Norman Zhou
Join now and verify your accreditation status to gain access to:
- Vivace Therapeutics Current Valuation
- Vivace Therapeutics Stock Price
- Vivace Therapeutics Management
- Available deals in Vivace Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vivace Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Vivace Therapeutics Revenue and Financials
- Vivace Therapeutics Highlights
- Vivace Therapeutics Business Model
- Vivace Therapeutics Risk Factors
- Vivace Therapeutics Research Report from SACRA Research
Trading Vivace Therapeutics Stock
How to invest in Vivace Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Vivace Therapeutics through EquityZen funds. These investments are made available by existing Vivace Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vivace Therapeutics stock?
Shareholders can sell their Vivace Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
